Literature DB >> 21316625

Porcine extracellular matrix scaffolds in reconstructive urology: An ex vivo comparative study of their biomechanical properties.

N F Davis1, A Callanan, B B McGuire, R Mooney, H D Flood, T M McGloughlin.   

Abstract

Functional reconstruction of the human urinary bladder has been attempted by replacing defective bladder tissue with tissue-engineered xenogenic extracellular matrix (ECM) scaffolds. However, experimental studies that demonstrate the effects of implanted ECMs on important biomechanical properties such as total bladder capacity (TBC) and compliance (C) are lacking. In the current study, the effects of ECM scaffold surface area (SA) on TBC and C was assessed, ex vivo, in an ovine model (n=5). TBC and C were measured at pressures (P) of 5, 10, 15 and 20 mm Hg prior to performing a 3×3 cm (9 cm(2)) partial cystectomy defect. Equal-sized 3×3 cm (9 cm(2)) and larger 6×6 cm (36 cm(2)) urinary bladder matrix (UBM) scaffolds of porcine origin replaced the 3×3 cm cystectomy defect, and TBC and C were re-recorded for comparative analysis. The results showed that TBC decreased by 39.6%±0.005% (122.9 ml±15 ml, p<0.05) and C by 38.9%±0.51%, (ΔP=0-5mmHg, p<0.05) in ovine bladders reconstructed with 3×3 cm UBM scaffolds compared to their native values. It was also found that TBC increased by 25.6±0.64% (64.2 ml ± 8.8 ml, p>0.05) and C by 24.5±0.43% (ΔP=0-5mmHg, p>0.05) in the 6×6 cm UBM scaffold group compared to the 3×3 cm UBM scaffold group; however, these values were not statistically significant. The present work demonstrates that a fourfold increase in ECM scaffold SA relative to its intended defect does not lead to a significant improvement in TBC and C values.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21316625     DOI: 10.1016/j.jmbbm.2010.11.005

Source DB:  PubMed          Journal:  J Mech Behav Biomed Mater        ISSN: 1878-0180


  7 in total

1.  Bladder reconstruction: The past, present and future.

Authors:  Omar M S El-Taji; Altaf Q Khattak; Syed A Hussain
Journal:  Oncol Lett       Date:  2015-04-28       Impact factor: 2.967

2.  A mathematical model for analyzing the elasticity, viscosity, and failure of soft tissue: comparison of native and decellularized porcine cardiac extracellular matrix for tissue engineering.

Authors:  Tomer Bronshtein; Gigi Chi Ting Au-Yeung; Udi Sarig; Evelyne Bao-Vi Nguyen; Priyadarshini S Mhaisalkar; Freddy Yin Chiang Boey; Subbu S Venkatraman; Marcelle Machluf
Journal:  Tissue Eng Part C Methods       Date:  2013-04-05       Impact factor: 3.056

3.  Recruitment of progenitor cells by an extracellular matrix cryptic peptide in a mouse model of digit amputation.

Authors:  Vineet Agrawal; Stephen Tottey; Scott A Johnson; John M Freund; Bernard F Siu; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2011-06-16       Impact factor: 3.845

Review 4.  Alloplastic bladder substitution: are we making progress?

Authors:  Marco Cosentino; Josep M Gaya; Alberto Breda; Joan Palou; Humberto Villavicencio
Journal:  Int Urol Nephrol       Date:  2012-07-21       Impact factor: 2.370

5.  Augmentation cystoplasty and extracellular matrix scaffolds: an ex vivo comparative study with autogenous detubularised ileum.

Authors:  Niall F Davis; Rory Mooney; Anthony Callanan; Hugh D Flood; Tim M McGloughlin
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

6.  Development of a porcine acellular bladder matrix for tissue-engineered bladder reconstruction.

Authors:  Massimo Garriboli; Koichi Deguchi; Giorgia Totonelli; Fanourios Georgiades; Luca Urbani; Marco Ghionzoli; Alan J Burns; Neil J Sebire; Mark Turmaine; Simon Eaton; Paolo De Coppi
Journal:  Pediatr Surg Int       Date:  2022-03-22       Impact factor: 1.827

Review 7.  Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative Interventions.

Authors:  Kuan-Wei Shih; Wei-Chieh Chen; Ching-Hsin Chang; Ting-En Tai; Jeng-Cheng Wu; Andy C Huang; Ming-Che Liu
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.